BeOne Medicines promotes Lai Wang to President, Global Head of R&D effective Jan 1, 2026

BeOne Medicines Ltd.

Dr. Lai Wang appointed President, Global Head of R&D, overseeing R&D, business development, and alliance management.
Promotion effective January 1, 2026; annual salary $750,000 with target bonus of 75% of base salary.
One-time RSU equity award of $10M vesting in equal annual installments over four years.
Dr. Wang had served as Global Head of R&D since April 2021 and joined the company in 2011.
No family relationships or material interests in transactions with directors or officers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.